amantadine has been researched along with resiquimod in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Bhardwaj, N; Fernandez, MV; Gopal, R; Greenbaum, BD; Krammer, F; Miller, E | 1 |
2 other study(ies) available for amantadine and resiquimod
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Ion efflux and influenza infection trigger NLRP3 inflammasome signaling in human dendritic cells.
Topics: Amantadine; Apoptosis; Caspase 1; Dendritic Cells; Humans; Imidazoles; Inflammasomes; Influenza A virus; Interferons; Interleukin-1; Ion Transport; Ions; Monocytes; NLR Family, Pyrin Domain-Containing 3 Protein; Rimantadine; Signal Transduction; Toll-Like Receptors; Up-Regulation | 2016 |